Skip to content

Opening book details…

About this Medicine article

AKT inhibitor ARQ 092 and sorafenib additively inhibit progression of hepatocellular carcinoma and improve immune system in cirrhotic rat model by Jilkova, Z.M. ;Kuyucu, A.Z. ;Kurma, K. ;Pour, S.T.A. ;Roth, G.S. ;Abbadessa, G. ;Yu, Y. ;Leroy, V. ;Marche, P. ;Decaens, T. is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Jilkova, Z.M. ;Kuyucu, A.Z. ;Kurma, K. ;Pour, S.T.A. ;Roth, G.S. ;Abbadessa, G. ;Yu, Y. ;Leroy, V. ;Marche, P. ;Decaens, T.
Publisher
Elsevier Science; Elsevier ; Elsevier BV; Wiley (ISSN 0168-8278)
Published
2017
Language
EN
Field
Medicine (Health Sciences)

More by Jilkova, Z.M. ;Kuyucu, A.Z. ;Kurma, K. ;Pour, S.T.A. ;Roth, G.S. ;Abbadessa, G. ;Yu, Y. ;Leroy, V. ;Marche, P. ;Decaens, T.

Browse all works by Jilkova, Z.M. ;Kuyucu, A.Z. ;Kurma, K. ;Pour, S.T.A. ;Roth, G.S. ;Abbadessa, G. ;Yu, Y. ;Leroy, V. ;Marche, P. ;Decaens, T.